share_log

JP Morgan Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $27

Moomoo 24/7 ·  Mar 12 09:09

JP Morgan analyst Brian Cheng maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from $29 to $27.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment